Study: Combination Therapy is an Effective Treatment for Cholangiosarcoma

A study conducted at the University of Texas has discovered that combination therapy may be a viable treatment for cholangiocarcinoma with BRAF mutations. Researchers treated participants with both dabrafenib and…

Continue Reading Study: Combination Therapy is an Effective Treatment for Cholangiosarcoma
Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?
source: pixabay.com

Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?

According to a story from curetoday.com, Dr. Tara Seery is an investigator in a phase 3 trial called PROOF, and she has just one goal: finding better treatments for cholangiocarcinoma,…

Continue Reading Could This Investigational Drug be the Latest Advancement for Cholangiocarcinoma?
New Designations for Infigratinib, a Treatment for Cholangiocarcinoma
source: pixabay.com

New Designations for Infigratinib, a Treatment for Cholangiocarcinoma

  BridgeBio Pharmaceuticals has recently announced that their drug, infigratinib, has received the Fast Track and Orphan Drug designations from the FDA. This drug is meant for the treatment of…

Continue Reading New Designations for Infigratinib, a Treatment for Cholangiocarcinoma

A Blood Test That Can Detect Seven Types of Cancer

  Health News Digest recently published an article that describes a simple blood test called DELFI, meaning DNA evaluation of fragments for early interception. Its simplicity belies the fact that it can detect…

Continue Reading A Blood Test That Can Detect Seven Types of Cancer
Close Menu